LGM Pharma

Alogliptin

CAS No: 850649-62-6

Alogliptin

LGM Pharma is a Alogliptin 850649-62-6 active pharmaceutical ingredient supplier distributor, based in the USA.

Questions? Call our customer API support number 1-(800)-881-8210.

LGM Pharma offers this active ingredient but not the finished dosage forms.

Inquire about Alogliptin

Product Details:

CAS No: 850649-62-6
Synonyms: 2-((6-((3R)-3-amino-1-piperidinyl)-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)- pyrimidinyl)methyl)benzonitrile monobenzoate, 6-((3R)-3-aminopiperidin-1-yl)-1-(2-cyanobenzyl)-3-methylpyrimidin-2,4(1H,3H)-dione monobenzoate, Alogliptin benzoate, SYR 322, SYR-322, UNII-EEN99869SC
ATC code: A10BH04
Molecular Weight: 339.39 g/mol
PubChem: 11450633
Chemical Formula: C18H21N5O2.C7H6O2
Assay/Purity: Typically NLT 98%
IUPAC Name: Benzonitrile, 2-((6-((3R)-3-amino-1-piperidinyl)-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl)methyl)-,monobenzoate
SMILES: n1(c(=O)cc(n(Cc2ccccc2C#N)c1=O)N1C[C,,H](CCC1)N)C.c1(ccccc1)C(=O)O
InChl: InChI=1S/C18H21N5O2.C7H6O2/c1-21-17(24)9-16(22-8-4-7-15(20)12-22)23(18(21)25)11-14-6-3-2-5-13(14)10-19;8-7(9)6-4-2-1-3-5-6/h2-3,5-6,9,15H,4,7-8,11-12,20H2,1H3;1-5H,(H,8,9)/t15-;/m1./s1

Alogliptin News:

  • Alogliptin was approved by the FDA on January 25, 2013 to treat type 2 diabetes.
  • Alogliptin is available in 3 forms: Nesina (alogliptin), Kazano (alogliptin and metformin HCl) 1 and Oseni (alogliptin and pioglitazone).
  • Kazano is a once daily single pill which combines alogliptin and metformin, alongside diet and exercise, to treat the symptoms of type 2 diabetes.
  • 23 million people on the United States suffer from type 2 diabetes, and this number is only expected to increase.

Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1).
Any patent infringement and resulting liability is solely at buyer risk.